TNFRSF17
genyn codio-protien yn y rhywogaeth Homo sapiens
Protein sy'n cael ei godio yn y corff dynol gan y genyn TNFRSF17 yw TNFRSF17 a elwir hefyd yn TNF receptor superfamily member 17 (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn blaen o gromosom dynol 16, band 16p13.13.[2]
TNFRSF17 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||
Dynodwyr | |||||||||||||||||
Cyfenwau | TNFRSF17, BCM, BCMA, CD269, TNFRSF13A, tumor necrosis factor receptor superfamily member 17, TNF receptor superfamily member 17 | ||||||||||||||||
Dynodwyr allanol | OMIM: 109545 HomoloGene: 920 GeneCards: TNFRSF17 | ||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
Orthologau | |||||||||||||||||
Species | Bod dynol | Llygoden | |||||||||||||||
Entrez |
| ||||||||||||||||
Ensembl |
| ||||||||||||||||
UniProt |
| ||||||||||||||||
RefSeq (mRNA) |
| ||||||||||||||||
RefSeq (protein) |
| ||||||||||||||||
Lleoliad (UCSC) | n/a | n/a | |||||||||||||||
PubMed search | [1] | n/a | |||||||||||||||
Wicidata | |||||||||||||||||
|
Cyfystyron golygu
Yn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn TNFRSF17.
- BCM
- BCMA
- CD269
- TNFRSF13A
Llyfryddiaeth golygu
- "Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients. ". Haematologica. 2017. PMID 28034989.
- "Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. ". Lupus. 2016. PMID 26424128.
- "Regulatory role of B-cell maturation antigen on the toxic effect of chromium ions on human SaOS-2 osteoblasts. ". Biotechnol Appl Biochem. 2017. PMID 26011700.
- "B-cell maturation antigen is modified by a single N-glycan chain that modulates ligand binding and surface retention. ". Proc Natl Acad Sci U S A. 2013. PMID 23776238.
- "B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.". Clin Cancer Res. 2013. PMID 23344265.